Racial and Socioeconomic Disparities in MRI-Fusion Biopsy Utilization to Assess for Prostate Cancer

Published:January 04, 2022DOI:



      To evaluate whether racial disparities in MRI-Bx usage persisted after correction for socioeconomic, demographic, and clinical factors.


      This is a retrospective cohort study of patients who received either MRI-Bx or systematic biopsy (SB) within a single academic medical center between January 2018 - June 2020. For each patient, socioeconomic variables including household income, education, percent below poverty, and unemployment were estimated using 2015 American Community Survey census-tract level data. Chi-square analysis was used to examine differences in clinical and demographic characteristics between the two groups. The Benjamini-Hochberg procedure was used to control false discovery rate (FDR) for multiple testing.


      Eighteen percent of Black men (53/295) received MRI-Bx while 41% (228/561) of white men received MRI-Bx. Patients coming from highly impoverished areas were less likely to receive MRI-Bx, 25% vs 75%, respectively. In multivariate analysis, race remained significantly different across MRI-Bx and SB groups. Clinical factors including family history, DRE, BMI, and prostate volume were not significantly different between patients receiving MRI-Bx and SB.


      Black men are less likely to receive MRI-Bx than white men, even after adjusting for clinical and socioeconomic characteristics. Further work is necessary to identify and study methods to increase equity in PCa diagnostic testing.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Siegel RL
        • Miller KD
        • Fuchs HE
        • et al.
        Cancer statistics, 2021.
        CA: A Cancer J Clinicians. 2021; 71: 7-33
        • Hoffman RM
        • Gilliland FD
        • Eley JW
        • et al.
        Racial and ethnic differences in advanced-stage prostate cancer: the prostate cancer outcomes study.
        J Natl Cancer Inst. 2001; 93: 388-395
        • DeSantis CE
        • Siegel RL
        • Sauer AG
        • et al.
        Cancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparities.
        CA Cancer J Clin. 2016; 66: 290-308
        • Kelly SP
        • Rosenberg PS
        • Anderson WF
        • et al.
        Trends in the incidence of fatal prostate cancer in the United States by race.
        Eur Urol. 2017; 71: 195-201
        • Underwood W
        • Jackson J
        • Wei JT
        • et al.
        Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.
        Cancer. 2005; 103: 538-545
        • Moses KA
        • Orom H
        • Brasel A
        • et al.
        Racial/ethnic disparity in treatment for prostate cancer: does cancer severity matter?.
        Urology. 2017; 99: 76-83
        • Hoffman RM
        • Harlan LC
        • Klabunde CN
        • et al.
        Racial differences in initial treatment for clinically localized prostate cancer.
        J Gen Intern Med. 2003; 18: 845-853
        • Dess RT
        • Hartman HE
        • Mahal BA
        • et al.
        Association of black race with prostate cancer-specific and other-cause mortality.
        JAMA Oncol. 2019; 5: 975-983
        • Major JM
        • Oliver MN
        • Doubeni CA
        • et al.
        Socioeconomic status, health care density, and risk of prostate cancer among African-American and Caucasian men in a large prospective study.
        Cancer Causes Control. 2012; 23: 1185-1191
        • Du XL
        • Fang S
        • Coker AL
        • et al.
        Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort.
        Cancer. 2006; 106: 1276-1285
        • Tyson MD
        • Castle EP
        Racial disparities in survival for patients with clinically localized prostate cancer adjusted for treatment effects.
        Mayo Clin Proc. 2014; 89: 300-307
        • Lu CD
        • Adeyemi O
        • Anderson WE
        • et al.
        Racial disparities in prostate specific antigen screening and referral to urology in a large, integrated health care system: a retrospective cohort study.
        J Urol. 2021; (101097JU0000000000001763)
        • Cheng I
        • Witte JS
        • McClure LA
        • et al.
        Socioeconomic status and prostate cancer incidence and mortality rates among the diverse population of California.
        Cancer Causes Control. 2009; 20: 1431-1440
        • Riviere P
        • Luterstein E
        • Kumar A
        • et al.
        Survival of African American and non-Hispanic white men with prostate cancer in an equal-access health care system.
        Cancer. 2020; 126: 1683-1690
        • Schoots IG
        • Roobol MJ
        • Nieboer D
        • et al.
        Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis.
        Eur Urol. 2015; 68: 438-450
        • Porpiglia F
        • Manfredi M
        • Mele F
        • et al.
        Diagnostic pathway with multiparametric magnetic resonance imaging vs standard pathway: results from a randomized prospective study in biopsy-naïve patients with suspected prostate cancer.
        Eur Urol. 2017; 72: 282-288
        • Siddiqui MM
        • Rais-Bahrami S
        • Turkbey B
        • et al.
        Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.
        JAMA. 2015; 313: 390-397
        • Hoge C
        • Verma S
        • Lama DJ
        • et al.
        Racial disparity in the utilization of multiparametric MRI-ultrasound fusion biopsy for the detection of prostate cancer.
        Prostate Cancer Prostatic Dis. 2020;
        • Benjamini Y
        • Hochberg Y
        Controlling the false discovery rate: a practical and powerful approach to multiple testing.
        J Royal Statist Soc. Series B (Methodological). 1995; 57: 289-300
        • Fletcher SA
        • Marchese M
        • Cole AP
        • et al.
        Geographic distribution of racial differences in prostate cancer mortality.
        JAMA Netw Open. 2020; 3 (Available at:) (accessed March 22, 2021)
        • Powell IJ
        • Bollig-Fischer A
        Minireview: the molecular and genomic basis for prostate cancer health disparities.
        Mol Endocrinol. 2013; 27: 879-891
        • Ajayi A
        • Hwang W-T
        • Vapiwala N
        • et al.
        Disparities in staging prostate magnetic resonance imaging utilization for nonmetastatic prostate cancer patients undergoing definitive radiation therapy.
        Adv Radiat Oncol. 2016; 1: 325-332
        • Optenberg SA
        • Thompson IM
        • Friedrichs P
        • et al.
        Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system.
        JAMA. 1995; 274: 1599-1605
        • Aizer AA
        • Chen M-H
        • McCarthy EP
        • et al.
        Marital status and survival in patients with cancer.
        J Clin Oncol. 2013; 31: 3869-3876
        • Huang T-B
        • Zhou G-C
        • Dong C-P
        • et al.
        Marital status independently predicts prostate cancer survival in men who underwent radical prostatectomy: an analysis of 95,846 individuals.
        Oncol Lett. 2018; 15: 4737-4744
        • Tyson MD
        • Andrews PE
        • Etzioni DA
        • et al.
        Marital status and prostate cancer outcomes.
        Can J Urol. 2013; 20: 6702-6706
        • Stokes WA
        • Hendrix LH
        • Royce TJ
        • et al.
        Racial differences in time from prostate cancer diagnosis to treatment initiation.
        Cancer. 2013; 119: 2486-2493
        • Neal RD
        • Allgar VL
        Sociodemographic factors and delays in the diagnosis of six cancers: analysis of data from the ‘National Survey of NHS Patients: cancer’.
        Br J Cancer. 2005; 92: 1971-1975
        • Siegel RL
        • Miller KD
        • Jemal A
        Cancer statistics, 2019.
        CA Cancer J Clin. 2019; 69: 7-34